Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
2.225
+0.075 (3.49%)
Nov 21, 2024, 2:51 PM EST - Market open

Envoy Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Net Income
-21.06-29.91-15.92-8.68
Depreciation & Amortization
0.170.130.080.07
Loss (Gain) From Sale of Assets
---0
Stock-Based Compensation
1.981.58--
Other Operating Activities
-0.0711.57.21.75
Change in Accounts Receivable
-0.09-0.030.05-0.02
Change in Inventory
-0.15-0.01-0.190.06
Change in Accounts Payable
-1.620.550.340.23
Change in Other Net Operating Assets
-4.44-1.47-0.36-0.35
Operating Cash Flow
-25.27-17.65-8.81-6.94
Capital Expenditures
-1.54-0.15-0.22-0.13
Investing Cash Flow
-1.54-0.15-0.22-0.13
Long-Term Debt Issued
-1088
Net Debt Issued (Repaid)
151088
Issuance of Common Stock
2.230.11--
Other Financing Activities
-11.740.090.06
Financing Cash Flow
14.3921.858.098.06
Foreign Exchange Rate Adjustments
-0.01-0-0.01-0.01
Net Cash Flow
-12.424.04-0.940.99
Free Cash Flow
-26.8-17.81-9.02-7.06
Free Cash Flow Margin
-9641.73%-5635.13%-3807.17%-2277.74%
Free Cash Flow Per Share
-1.36-1.42-0.89-0.70
Levered Free Cash Flow
-6.57-6.54-5.17-
Unlevered Free Cash Flow
-6.3-6.54-5.17-
Change in Net Working Capital
-6.5-3.39-0.41-
Source: S&P Capital IQ. Standard template. Financial Sources.